TrialJAMA network open2025

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.

Arun A Azad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.